Feed/Companies/UltraSight

UltraSight

As of 8 Nov 2026, UltraSight has raised $37M across 2 verified rounds on record; latest: $24 million Series B led by Alive HealthTech Growth Fund, announced 23 Sep 2026.

BUILT ON

UltraSight makes an AI-guided cardiac ultrasound platform that helps clinicians perform focused echocardiograms.

ultrasight.comLinkedInRehovot, IsraelHealthtechFounded 201825 people (19 in Israel and the remainder in the U.S.)

LATEST ROUND

Series B

$24M · 2026-09-23

RAISED ON RECORD · USD

$37M

across 2 verified rounds

INVESTORS

1 lead

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Rounds

[ 2 ]

Series BSeries B2

$24M · 2026-09-23

led by Alive HealthTech Growth Fund

Series B

$13M · 2021-05-11

[ HISTORY ]

lead not stated

Round	Amount	Announced	Lead	Buzz
Series B Series B2	$24M	2026-09-23	Alive HealthTech Growth Fund	No recent discussion
21 sources · checked 1 time, last 42d ago [ VERIFIED ] read against 4 of 21 sources The company release says “Alive HealthTech Growth Fund”; MassDevice says “Alive HealthTech Grow Fund.” The company’s wording wins. The September 28 articles are republished coverage; the company release fixes the announcement date as September 23.

On

1 person on 16 outlets

The Jerusalem Post@jerusalem_post46d agoAn Israeli-led company specialized in AI-guided cardiac sonography called UltraSight announced that it had raised $24 million in Series B2

Found on X with Firecrawl search

Company research

Fetched Sep 24

UltraSight builds AI software that guides healthcare providers through cardiac ultrasound so hospitals can expand access to diagnostic heart imaging.

Founders

Itay Kezurer · Co-Founder and Chief Technology Officer
UltraSight says he was previously an algorithmic engineer at Elbit Systems, brings computer-vision and computer-graphics expertise, and holds an MSc in Applied Mathematics and Computer Science from the Weizmann Institute of Science and a BSc in Electrical Engineering from Ben-Gurion University.
Yaron Lipman, PhD · Co-Founder and Chief Scientific Officer
UltraSight says he is an associate professor at the Weizmann Institute of Science, holds a PhD from Tel Aviv University, did postdoctoral work at Princeton University, and researches geometric modeling and geometric deep learning.
Achi Ludomirsky, MD · Co-Founder and Chief Medical Officer
UltraSight says he is a professor of pediatric cardiology and pediatrics and associate chair of Pediatric Outreach at NYU School of Medicine, and a pioneer in fetal and pediatric heart imaging.
Davidi Vortman · CEO and Co-Founder
UltraSight says he has more than 20 years of experience as a technology entrepreneur, founded and grew Lumos Global, Comverse Technologies and NICE Systems, and holds a computer-science BSc from the Hebrew University and an MBA from Kellogg-Recanati at Northwestern University.

Total raised

$42 million

UltraSight

Company

Rounds

Sources

Profile

Investors

UltraSight

Rounds

On

Company research

Sources

Series B$24M2026-09-2321 sources

Series B$13M2021-05-112 sources

Investors

Series B$24M2026-09-239 investors

Series B$13M2021-05-113 investors

Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$13M	2021-05-11	not stated	No recent discussion
2 sources [ VERIFIED · CORRECTED ] read against 1 of 2 sources [ BUILT WITH ]·[ SEARCH ]found by Firecrawl search·[ SCRAPE ]2 pages read: ultrasight.com, prnewswire.com·[ JSON ]round read into a schema, with the sentence that states it·[ VERIFY ]correctedchecked against 1 of 2 sources·[ BRANDING ]logo and colour from the homepage·[ AGENT ]company research by the Firecrawl agent